Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.40 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.40 |
| ▸ | ADRA2B | P18089 | 2/20 | 0.40 |
| ▸ | ADRA2C | P18825 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4729505 | 0.80 | TAAR1 (0.54) | TAAR1PTGS1PTGS2ADRA2AADRA2B | |
| SCHEMBL12719654 | 0.80 | KMT2A (0.35) | ADRA2BADRA2CHTTPOLBCYP2C19 | |
| Ammonia Solution, Strong SCHEMBL28852825 | 0.79 | TAAR1 (0.52) | TAAR1PTGS1PTGS2ADRA2AADRA2B | |
| SCHEMBL1079558 | 0.79 | ALOX5 (0.40) | TSHRPOLBRAB9AKMT2AALOX5 | |
| SCHEMBL8097235 | 0.78 | TAAR1 (0.47) | TAAR1PTGS1PTGS2ADRA2AADRA2B | |
| SCHEMBL23094084 | 0.77 | TAAR1 (0.50) | TAAR1PTGS1PTGS2ADRA2AADRA2B | |
| SCHEMBL12808832 | 0.77 | ALOX5 (0.39) | ADRA2BADRA2CHTTPOLBCYP2C19 | |
| SCHEMBL10728212 | 0.77 | KMT2A (0.50) | TAAR1PTGS1PTGS2ADRA2AADRA2B | |
| SCHEMBL5481200 | 0.77 | ALOX5 (0.42) | ADRA2BADRA2CTSHRHTTPOLB | |
| SCHEMBL9685393 | 0.77 | KMT2A (0.50) | TAAR1PTGS1PTGS2ADRA2AADRA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3321291-B1 | CATALYST COMPOSITION COMPRISING NOVEL TRANSITION METAL COMPOUND | LG CHEMICAL LTD (KR) | 2022-05-18 | — | — | EP | disclosed |
| US-10947327-B2 | Catalyst composition including novel transition metal compound | LG CHEM, LTD. | 2021-03-16 | — | — | US | disclosed |
| US-20180201697-A1 | CATALYST COMPOSITION INCLUDING NOVEL TRANSITION METAL COMPOUND | LG CHEM, LTD. (KR) | 2018-07-19 | — | — | US | disclosed |
| EP-3321291-A1 | CATALYST COMPOSITION COMPRISING NOVEL TRANSITION METAL COMPOUND | LG Chem, Ltd. (KR) | 2018-05-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10947327-B2 | Catalyst composition including novel transition metal compound | COG4, MCM4, ZNF436-AS1 | TAAR1 3759/4885PTGS1 221/4885PTGS2 176/4885 |
| US-20180201697-A1 | CATALYST COMPOSITION INCLUDING NOVEL TRANSITION METAL COMPOUND | COG4, MCM4, ZNF436-AS1 | TAAR1 3759/4885PTGS1 221/4885PTGS2 176/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.